The syringes market is expected to reach USD 15.99 billion by 2021, at a CAGR of 8.7% from 2016 to 2021.
The syringes market is primarily driven by the high prevalence of chronic diseases across the globe. In addition, rising geriatric population, increasing adoption of safety syringes, technological advancements, and increasing demand for vaccines are supporting the growth of this market. On the other hand, high cost of safety syringes and increasing incidence of needle stick injuries are the major challenges in this market.
In this report, the syringes market has been segmented On the basis of usability (sterilizable/reusable syringes and disposable syringes), type (general syringes and specialized syringes), material (glass and plastic), and region (North America, Europe, APAC, and RoW).
On the basis of usability, the global syringes market is segmented into two broad categories, namely, sterilizable/reusable syringes and disposable syringes. The disposable syringes market is estimated to command the larger share of the global syringes market in 2016. The large share of this segment can be attributed to the increasing use of injectables as a mode of drug delivery, growing aging population, high infection risks associated with reusable syringes, and increasing inclination towards self-administration.
Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the syringes market in 2016, followed by Europe. The increasing prevalence of chronic and lifestyle diseases, growing product approvals, increasing awareness about specialized syringes, upsurge in biologics approvals, and increasing development of injectables are the major factors driving market growth in North America. However, the increasing cases of needlephobia and low adoption of biosimilars as compared to other regions are hindering market growth in North America.
The syringes market consists of a large number of big, medium, and small-sized companies. As of 2015, the syringes market was dominated by Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), Medtronic plc (Ireland), and B. Braun Medical Inc. (U.S.). New product launches and product approvals; partnerships and collaborations; and expansions; were the major strategies adopted by most of the market players between 2013 and 2016 to achieve growth in the syringes market.
Research Coverage This report studies the syringes market based on usability, type, and material. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, future prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions
Reasons to Buy the Report: From an insights perspective, this research report has focused on various levels of analysis—industry trends, market share analysis of top ten players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the syringes market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers: • Market Penetration: Comprehensive information on product portfolios and services offered by the major players in the syringes market. The report analyzes the syringes market based on usability, type, material and region
• Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the syringes market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various syringe products across geographies
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the syringes market
• Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the syringes market
Our reports have been used by over 10K customers, including:
The global injectables market is estimated to reach US$759.61 billion in 2025, progressing at a CAGR of 10.95%, over the period 2021-2025. Factors such as increasing geriatric population, upsurge in demand for convenient drug delivery, expanding use of biologics, rising healthcare expenditure and surging incidence of cancer cases would drive...
The major factors for the growth of the novel drug delivery systems (NDDS) market include the growing need of controlled release of drugs, advancement in pharmacology promoting increased adoption of novel drug delivery systems (NDDS), and technological advancements promoting the development of NDDS. There has been a remarkable increase...
Rising prevalence for chronic diseases and growth in the biologics market are expected to drive the overall growth of the pharmaceutical drug delivery market. The global pharmaceutical drug delivery market is projected to reach USD 2,015.3 billion by 2025 from USD 1,430.5 billion in 2020, at a CAGR of 7.1% during the forecast period 2020-2025....
The Europe wearable injectors market is expected to reach US$ 3586.82 million in 2027 from US$ 1539.88 million in 2019. The market is estimated to grow with a CAGR of 11.3 % from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...
The Asia Pacific Wearable Injectors market is expected to reach US$ 2939.97 million by 2027 from US$ 1160.40 million in 2019. The market is estimated to grow at CAGR of 12.4% from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...
510 pages •
By Roots Analysis Private Ltd.
• May 2020
Chronic diseases, such as diabetes, cardiovascular disorders, neurological disorders, autoimmune disorders and various types of cancer, are known to be the leading causes of death and disability across the world. The clinical conditions associated with these diseases affect patients’ overall quality of life....
The liposome drug delivery market is expected to reach US$ 6,992.95 million by 2027 from US$ 3,594.41 million in 2019. The market is estimated to grow at a CAGR of 8.8% from 2020 to 2027.
The growth of the market is attributed to a few key driving factors such as increasing prevalence of chronic diseases, growing demand for noninvasive...
The bioresorbable medical material was valued at US$ 935.99 million in 2019 and is expected to grow at a CAGR of 9.7% from 2020 to 2027 to reach US$ 1,942.13 million by 2027. Driving factors of the bioresorbable medical material market are rising adoption of bioresorbable polymers for medical use and increasing number of orthopedic...
The electronic drug delivery systems market is projected to grow at a CAGR of 8.7% during the forecast period (2019–2024). The electronic drug delivery systems market is projected to reach USD 11.9 billion by 2024 from USD 7.8 billion in 2019, at a CAGR of 8.7%. The growth of the electronic drug delivery systems market...
The Europe drug delivery systems market is expected to reach US$ 610,320.4 Mn in 2027 from US$ 343,533.9 in 2018. The market is estimated to grow with a CAGR of 6.7% from 2019-2027. Factors such as rising investments by pharmaceutical companies and medical device companies in research and development and rise of chronic disease conditions...
Chronic Disease Prevalence
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.